A Loop Within the MRG Domain of Drosophila MSL3 Interacts with C2H2 Proteins and Is Involved in Dosage Compensation
Dosage compensation in Drosophila melanogaster is mediated by the male-specific lethal (MSL) complex, which includes an MSL1–MSL3–MOF sub-complex with acetyltransferase activity and an MSL2–MLE subcomplex organized by roX RNAs. The N-terminal coiled-coil domain of MSL1 forms a dimer and interacts with MSL2, while the C-terminal PEHE domain of MSL1 interacts with MOF and MSL3. Inactivation of MSL3 significantly disrupts the specific binding of MSL1–MSL2–MLE to the X chromosome in embryos, suggesting that MSL3 is involved in the recruitment of the entire MSL complex. In this study, using an msl-3 gene deletion, we confirmed that complete inactivation of MSL3 results in a severe reduction in MSL1 and restricts MSL1–MSL2 recruitment to only a small number of X-chromosome sites in larvae and adults. Furthermore, we identified DNA-binding transcription factors that predominantly interact with the MRG (MORF4-related gene) domain of MSL3. This MRG domain contains a disordered loop; deleting this loop (MSL3ΔL) did not affect the MSL3–MSL1 interaction, but disrupted MSL3 binding to the majority of the identified transcription factors. Males expressing the MSL3ΔL variant exhibited reduced viability, indicating partially impaired dosage compensation, although binding of the MSL complex to the X chromosome remained largely unaffected. In contrast, when the MSL complex was formed in females via ectopic MSL2 and roX2 expression, wild-type MSL3 effectively bound the X chromosome at both the larval and imaginal stages. However, under these conditions, the MSL3ΔL variant lost the ability to interact effectively with MSL1, resulting in a near-complete absence of MSL complex binding to the X chromosome. Together, these results demonstrate the intricate regulation of MSL complex formation, the mechanisms of which are not yet fully understood.
Authors
- Olga V. Arkova (ORCID: https://orcid.org/0000-0002-5353-0748)
- Varvara E. Ryzhkova (ORCID: https://orcid.org/0000-0002-6568-7355)
- Oksana G Maksimenko (ORCID: https://orcid.org/0000-0003-3502-0303)
- Valentin Babosha (ORCID: https://orcid.org/0000-0003-0402-3915)
- Anna V. Tvorogova (ORCID: https://orcid.org/0000-0002-8205-1914)
- Anastasia Revel-Muroz (ORCID: https://orcid.org/0000-0002-6517-1375)
- Yuliya V. Vasileva (ORCID: https://orcid.org/0000-0001-5192-3073)
- Evgeniya Tikhonova
- Pavel Georgiev
- Evgeniy Kozlov
Institutions
- Russian Academy of Sciences (RU)
- Institute of Gene Biology (RU)
Publication Details
- Journal
- International Journal of Molecular Sciences
- Published
- 2026-11-16
- DOI
- https://doi.org/10.3390/ijms272210271
- Primary Topic
- Genetic and Clinical Aspects of Sex Determination and Chromosomal Abnormalities
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Russian Science Foundation